Medicare Enrolled
Dr. Frank Lin, M.D.
Cardiovascular Disease · Covina, CA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Lin from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Lin?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Lin
Dr. Frank Lin is a cardiovascular disease specialist in Covina, CA, with 15 years of NPI registration. Based on federal Medicare data, Dr. Lin performed 2,418 Medicare services across 1,385 unique beneficiaries.
Between the years covered by Open Payments, Dr. Lin received a total of $19,795 from 44 pharmaceutical and/or device companies across 792 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in cardiovascular disease. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Lin is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 15 years in practice
▲ Top 42% volume in CA
$19,795 industry payments
Medicare Practice Summary
Medicare Utilization ↗2,418
Medicare services
Top 42% in CA for cardiovascular disease
1,385
Unique beneficiaries
$85
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~161 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
678 | $68 | $225 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
383 | $102 | $250 |
| Echocardiogram, transthoracic An ultrasound of the heart that uses color to show blood flow, rate, direction, and valve function. |
238 | $173 | $940 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
216 | $146 | $600 |
| Remote patient monitoring device, 30 days Initial setup of devices for remote monitoring of body functions with daily data transmission or alerts. This service covers the first 30 days of the monitoring period. |
205 | $47 | $223 |
| Electrocardiogram (EKG), 12-lead A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report. |
186 | $12 | $80 |
| Remote patient monitoring management, 20 min/month Management based on results from remote vital sign monitoring for the first 20 minutes per calendar month. |
177 | $43 | $170 |
| Remote vital sign monitoring management, each additional 20 minutes This code covers the time spent by a provider managing patient data from remote vital sign monitoring devices. It applies to each additional 20-minute increment beyond the initial monthly service period. |
103 | $35 | $135 |
| Psychiatric collaborative care follow-up, first 60 minutes A follow-up psychiatric care management visit for subsequent calendar months. The service covers the first 60 minutes of collaborative care coordination. |
76 | $124 | $511 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
52 | $132 | $425 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
27 | $67 | $175 |
| Remote physiologic monitoring setup and education Initial setup of remote monitoring equipment and patient education on its use. |
27 | $18 | $67 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
25 | $102 | $325 |
| Cardiac catheterization | 13 | $213 | $1,000 |
| Initial psychiatric collaborative care management, first 70 minutes This service covers the first 70 minutes of psychiatric collaborative care management during the initial calendar month of treatment. |
12 | $135 | $513 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
10.4% high complexity
0.0% medium
89.6% routine
Industry Payment Transparency
Open Payments through 2024 ↗$19,795
Total received (2018-2024)
Avg $2,828/year across 7 years
Top 17% in CA for cardiovascular disease
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
44
Companies
792
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$19,795 (100.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$2,249
2023
$1,766
2022
$2,577
2021
$2,964
2020
$1,629
2019
$4,492
2018
$4,118
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Medtronic, Inc.
$504
Novartis Pharmaceuticals Corporation
$245
ATRICURE, INC.
$180
ABIOMED
$177
Abbott Laboratories
$174
E.R. Squibb & Sons, L.L.C.
$144
Edwards Lifesciences Corporation
$143
PFIZER INC.
$139
Kiniksa Pharmaceuticals International, plc
$123
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$93
Novo Nordisk Inc
$75
Lexicon Pharmaceuticals, Inc.
$69
Boehringer Ingelheim Pharmaceuticals, Inc.
$59
Boston Scientific Corporation
$38
Amgen Inc.
$31
Janssen Pharmaceuticals, Inc
$19
Celgene Corporation
$18
Merck Sharp & Dohme LLC
$17
Top 3 companies account for 41.3% of 2024 payments
All-time payments by company (2018-2024) ›
Abbott Laboratories
$4,049
Novartis Pharmaceuticals Corporation
$2,053
ABIOMED
$1,605
Edwards Lifesciences Corporation
$1,163
PFIZER INC.
$1,159
Boston Scientific Corporation
$1,023
Medical Device Business Services, Inc.
$996
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$916
Medtronic, Inc.
$905
Amgen Inc.
$822
Janssen Pharmaceuticals, Inc
$674
E.R. Squibb & Sons, L.L.C.
$673
AstraZeneca Pharmaceuticals LP
$539
Boehringer Ingelheim Pharmaceuticals, Inc.
$370
Medtronic Vascular, Inc.
$315
SANOFI-AVENTIS U.S. LLC
$295
Impulse Dynamics (USA) Inc.
$226
Kiniksa Pharmaceuticals, Ltd.
$195
ATRICURE, INC.
$180
BOSTON SCIENTIFIC CORPORATION
$171
Amarin Pharma Inc.
$153
Kiniksa Pharmaceuticals International, plc
$123
Merck Sharp & Dohme Corporation
$107
CARDIVA MEDICAL, INC.
$99
Chiesi USA, Inc.
$96
Esperion Therapeutics, Inc.
$90
Gilead Sciences, Inc.
$81
HeartFlow, Inc.
$76
Novo Nordisk Inc
$75
Kowa Pharmaceuticals America, Inc.
$71
Lexicon Pharmaceuticals, Inc.
$69
CathWorks, Inc.
$64
Merck Sharp & Dohme LLC
$55
Kestra Medical Technology Services, Inc.
$51
Akcea Therapeutics, Inc.
$47
Invuity, Inc.
$36
Radius Health, Inc.
$33
Cardiovascular Systems Inc.
$32
Terumo Medical Corporation
$25
La Jolla Pharmaceutical Company
$22
Actelion Pharmaceuticals US, Inc.
$19
Celgene Corporation
$18
AtriCure, Inc.
$14
GE HEALTHCARE
$11
Top 3 companies account for 38.9% of all-time payments
Associated products mentioned in payments ›
ACCOLADE · ATRICLIP LAA EXCLUSION SYSTEM · AVEIR · AngioSeal · Arcalyst · Assure WCD · Azure · BRILINTA · CAMZYOS · CARDIOMEMS · CARDIVA VASCADE 6/7F VCS · CHANTIX · CardioMEMS HF System · CareLink · Carto 3 System · Claria MRI · Confirm Rx · CoreValve Evolut · Corlanor · Dragonfly OCT · EDWARDS SAPIEN 3 TRANSCATHETER HEART VALVE (THV) · ELIQUIS · EMBLEM · EMBLEM MRI S-ICD · EMBLEM S ICD ELECTRODE DELIVERY SYSTEM · ENTRESTO · EPI-SENSE GUIDED COAGULATION SYSTEM WITH VISITRAX · Edwards SAPIEN 3 Transcatheter Heart Valve · Edwards SAPIEN 3 Ultra Transcatheter Heart Valve · EkoSonic · FARXIGA · FFRangio System · FFRct · GENERAL BRADY · GENERAL THERAPIES · GENERAL THERAPIES · GENERAL - THERAPIES · GIAPREZA · Impella · JARDIANCE · KENGREAL · LATITUDE · LEQVIO · LOKELMA · LUX DX · LUX-DX · LifeVest · Livalo · MICRA · MITRACLIP · MULTAQ · MYLUX · Micra · Mitra Clip system · MitraClip System · MyCareLink · NEXLETOL · ONYX FRONTIER · OPSUMIT · OPTIMIZER · Optimizer · Ozempic · PRADAXA · PRALUENT · PRESSUREWIRE · Peripheral Orbital Atherectomy System · Photonblade · Quadra Assura CRT Defibrillator · RESONATE · RESONATE EL ICD VR · Repatha · Reveal LINQ · Rybelsus · S ICD · S-ICD System Magnet · SAPIEN 3 Ultra RESILIA · SQ RX PULSE GENERATOR · SYMPLICITY G3 · TEGSEDI · TactiCath Quartz CFA Catheter · Tymlos · VERQUVO · VIGILANT · VYNDAQEL · Vascepa · WATCHMAN · WATCHMAN Access System · WATCHMAN FLX · XARELTO · Xience Alpine cornary stent system · Xience Sierra Coronary Stent · Xience Sierra Coronary Stent System · Xience V coronary stent system
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Cardiologists within 10 mi
379
Per 100K population
3.8
County median income
$87,760
Nearest hospital
EMANATE HEALTH INTER-COMMUNITY HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Lin is a clinical cardiology specialist, with moderate Medicare volume, with low-engagement industry engagement in the top 17% of CA peers, with 15 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Lin experienced with hospital follow-up visit, moderate complexity?
Based on Medicare claims data, Dr. Lin performed 678 hospital follow-up visit, moderate complexity services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Lin receive payments from pharmaceutical companies?
Yes. Dr. Lin received a total of $19,795 from 44 companies across 792 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Lin's costs compare to other cardiologists in Covina?
Dr. Lin's average Medicare payment per service is $85. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Lin) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Cardiologists in Covina
Browse cardiologists in Covina ranked by procedure volume and transparency data.
Highest volume
Top Cardiologists in CA
Cardiologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Cardiologists in CA
Which CA cardiologists receive the most from drug and device companies.
By company
Abbott Laboratories Payments to Doctors
See all physicians who received payments from Abbott Laboratories.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
ABIOMED Payments to Doctors
See all physicians who received payments from ABIOMED.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology